- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03539510
Effectiveness of the HF-ACP Website Study
28 maj 2018 uppdaterad av: Jane MacIver, University Health Network, Toronto
Randomized Controlled Trial of an Interactive Website for Heart Failure Advance Care Planning
This study evaluates the effectiveness of an interactive website on advance care planning for patients living with heart failure (HF-ACP website).
The investigators will randomize patients to either the HF-ACP website or usual care to determine if the participants who use the HF-ACP website have higher advance care planning completion rates than participants assigned to usual care.
Studieöversikt
Status
Okänd
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Advance care planning is a process that supports adults at any age or stage of health to understand and share their personal values, life goals and preferences in order to prepare for future decisions regarding medical care.
Public awareness campaigns to promote ACP have been taking place for about 10 years without significant improvements in ACP completion rates.
Content intended for use by the general public may be too vague for those living with a chronic illness.
Framing ACP within the context of a specific disease may provide the impetus for a person to engage in ACP.
The investigators believe the HF-ACP website will improve patient understanding of the life-limiting nature of HF, the ACP process and the need to plan ahead to help ensure the care they receive matches their treatment preferences.
Studietyp
Interventionell
Inskrivning (Förväntat)
20
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- over the age of 18,
- a regular patient in our clinic,
- able to read and write English,
- familiar with the use and have access to a personal computer, email and the internet.
Exclusion Criteria:
- ineligible for participation in the trial if they do not meet the inclusion criteria described above.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: HF-ACP Website
The HF-ACP website leads participants through 4 e-learning modules.
Each module contains 3 core elements: (1) educational content which provides information and support to help patients complete the module (2) interactive tools for documenting their thoughts and progress and (3) motivational video clips that encourage behavior change by validating participants ambivalence, suggesting strategies to help participants complete the task and to encourage and reassure participants that they can do this.
|
Each module is broken down into weekly topics and each module takes 3-6 weeks to complete.
Participants can access and review the material as often as needed as well as revisiting the information from modules they have completed.
|
|
Inget ingripande: Usual Care
The standard of care for advance care planning at our institution is the "Speak Up" booklet and the Power of Attorney workbook from the Attorney General's Office - Ontario.
Patients randomized to the Control arm will be asked to register on a separate research portal where participants will have electronic access to both of the booklets and a link to the Speak Up online Interactive workbook.
There is no specific information on HF or HF treatments.
Participants in the control arm will be asked to complete the ACP using the interactive workbook.
Participants in the control arm will not receive any additional communication from the research team about their progress.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Advance care planning completion rates
Tidsram: 6 months
|
proportion of participants who complete the advance care planning process
|
6 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
advance care planning knowledge
Tidsram: 6 months
|
% improvement in knowledge of advance care planning
|
6 months
|
|
The 5-level European Quality of Life scale
Tidsram: 6 months
|
The EQ-5D-5L is a generic quality of life measure that consists of a 5-item health state assessment and a visual analog scale.
The dimensions represented in the 5-item assessment include: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Responses to the questions can be converted to a time tradeoff utility score from 0 (represents worst possible health) to 1.0 (represents perfect health).
The visual analog scale ranges from 0-100 with higher scores representing better quality of life.
|
6 months
|
|
Generalized Anxiety Disorder Scale (GAD-7)
Tidsram: 6 months
|
The GAD-7 is a 7 item self-administered screening tool for anxiety.
Scores range from 0-21 with cutoffs at 5, 10, and 15 representing mild, moderate and severe anxiety, respectively.
|
6 months
|
|
The Readiness to Change Scale (RCS)
Tidsram: 6 months
|
The RCS is a study-specific tool based on Prochaska's algorithm for change.
It categorizes participants into one of the 5 categories of readiness.
The RCS will be used to measure change for the 3 discreet behaviors: (1) identifying a SDM, (2) developing the advance care plan and (3) communicating wishes to their SDM.
The RCS will be used to determine if readiness is associated with ACP completion
|
6 months
|
|
The Patient Health Questionnaire (PHQ-9)
Tidsram: 6 months
|
The PHQ -9 is a 9 item self-administered scale screening tool for depression.
Scores range from 0-27 with cutoffs at 5, 10, 15 and 20 representing mild, moderate, moderately severe and severe depression
|
6 months
|
|
The Perceived Stress Scale
Tidsram: 6 months
|
The PSS is a 10 item self-administered scale to measure perceived stress.
The scores range form 0-40 with higher scores representing greater stress.
|
6 months
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Utredare
- Huvudutredare: Jane Maciver, RN PhD, UHN Toronto
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Förväntat)
1 maj 2018
Primärt slutförande (Förväntat)
1 december 2018
Avslutad studie (Förväntat)
1 april 2019
Studieregistreringsdatum
Först inskickad
4 juli 2017
Först inskickad som uppfyllde QC-kriterierna
16 maj 2018
Första postat (Faktisk)
29 maj 2018
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
30 maj 2018
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
28 maj 2018
Senast verifierad
1 maj 2018
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- HF-ACP website
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .